IHM
ZSAN

Iguana Healthcare Management’s Zosano Pharma Corporation ZSAN Stock Holding History

Iguana Healthcare Management’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$2.52M Buy
+14,286
New +$4.78M 1.66% 25

Other funds holding ZSAN

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Iguana Healthcare Management's ZSAN Position: Q1 2018 in Review

Iguana Healthcare Management opened a new position in Zosano Pharma Corporation (ZSAN) in Q1 2018: 14,286 shares worth $2.52M. The stake represents 1.66% of the portfolio and ranks #25 among its holdings.

32 funds tracked by Wall St. Rank hold ZSAN as of Q1 2018.

  • Iguana Healthcare Management held 14,286 shares of Zosano Pharma Corporation worth $2.52M as of Q1 2018.
  • Zosano Pharma Corporation was a new Iguana Healthcare Management position in Q1 2018.
  • Zosano Pharma Corporation made up 1.66% of Iguana Healthcare Management's portfolio in Q1 2018, its #25 holding.
  • 32 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.